Biotech Watch

complete, accurate, and up-to-date information on publicly traded biotechnology companies

Biotech Watch Home
 

Estimate of 10-Year Risk for Coronary Heart Disease
Framingham Point Scores






Estimate of 10-Year Risk for Men

Framingham Point Scores by Age Group

AgePoints
20-34-9
35-39-4
40-440
45-493
50-546
55-598
60-6410
65-6911
70-7412
75-7913


Framingham Point Scores by Age Group and Total Cholesterol

Total CholesterolAge 20-39Age 40-49Age 50-59Age 60-69Age 70-79
<16000000
160-19943210
200-23975310
240-27996421
280+118531

Framingham Point Scores by Age and Smoking Status

 Age 20-39Age 40-49Age 50-59Age 60-69Age 70-79
Nonsmoker00000
Smoker 85311


Framingham Point Scores by HDL Level

HDLPoints
60+-1
50-590
40-491
<402


Framingham Point Scores by Systolic Blood Pressure and Treatment Status

Systolic BPIf UntreatedIf Treated
<12000
120-12901
130-13912
140-15912
160+23


10-Year Risk by Total Framingham Point Scores

Point Total10-Year Risk
< 0< 1%
01%
11%
21%
31%
41%
52%
62%
73%
84%
95%
106%
118%
1210%
1312%
1416%
1520%
1625%
17 or moregreater than or equal to 30%




Estimate of 10-Year Risk for Women

Framingham Point Scores by Age Group

AgePoints
20-34-7
35-39-3
40-440
45-493
50-546
55-598
60-6410
65-6912
70-7414
75-7916


Framingham Point Scores by Age Group and Total Cholesterol

Total CholesterolAge 20-39Age 40-49Age 50-59Age 60-69Age 70-79
<16000000
160-19943211
200-23986421
240-279118532
280+1310742


Framingham Point Scores by Age and Smoking Status

 Age 20-39Age 40-49Age 50-59Age 60-69Age 70-79
Nonsmoker 00000
Smoker97421


Framingham Point Scores by HDL Level

HDLPoints
60+ -1
50-590
40-491
<402


Framingham Point Scores by Systolic Blood Pressure and Treatment Status

Systolic BPIf UntreatedIf Treated
<12000
120-12913
130-13924
140-15935
160+46


10-Year Risk by Total Framingham Point Scores

Point Total10-Year Risk
< 9< 1%
91%
101%
111%
121%
132%
142%
153%
164%
175%
186%
198%
2011%
2114%
2217%
2322%
2427%
25 or moregreater than or equal to 30%